Core Laboratories CLB Provision for Loan, Lease, and Other Losses

Provision for Loan, Lease, and Other Losses at other companies

NCS Multistage HoldingsNCSM

——

Revenue$121.8M-1.4%

Operating income$1.9M-57.3%

Net income-$789.0K-412%

EPS (diluted)-$0.02—

Cash & equivalents$22.8M+3.2%

Total debt$167.8M-6.8%

Total equity$268.9M+6.1%

Total assets$587.7M+0.3%

Operating cash flow$4.0M-40.5%

CapEx$3.4M+23.8%

Free cash flow$517.0K-86.7%

Market cap$537.03M-4.5%

Enterprise value$682.05M-3.9%

P/E18.5×-0.5×

P/S1×-0.1×

Operating margin10.3%-0.2pp

Net margin5.5%+0.1pp

FCF margin4.3%-4.6pp

Return on equity11.1%-0.4pp

Debt / equity0.6×-0.1×

Current ratio2×-0.2×

Reported directly by Core Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForLoanLeaseAndOtherLosses.

The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Core Laboratories's provision for loan, lease, and other losses?: Core Laboratories (CLB) reported provision for loan, lease, and other losses of $241K in Q1 2026.
How has Core Laboratories's provision for loan, lease, and other losses changed year-over-year?: Core Laboratories's provision for loan, lease, and other losses decreased by 63.9% year-over-year, from $668K to $241K.